Archimedes Tech SPAC Partners II Co. Ordinary Shares (ATII) - Total Liabilities
Based on the latest financial reports, Archimedes Tech SPAC Partners II Co. Ordinary Shares (ATII) has total liabilities worth $8.18 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ATII cash generation efficiency to assess how effectively this company generates cash.
Archimedes Tech SPAC Partners II Co. Ordinary Shares - Total Liabilities Trend (2024–2024)
This chart illustrates how Archimedes Tech SPAC Partners II Co. Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. See Archimedes Tech SPAC Partners II Co. Ord net assets for net asset value and shareholders' equity analysis.
Archimedes Tech SPAC Partners II Co. Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of Archimedes Tech SPAC Partners II Co. Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Primis Financial Corp
NASDAQ:FRST
|
USA | $3.62 Billion |
|
NEOWIZ
KQ:095660
|
Korea | ₩103.67 Billion |
|
Ercros
MC:ECR
|
Spain | €396.07 Million |
|
Cosmo Electronics Corp
TW:2466
|
Taiwan | NT$2.23 Billion |
|
Jiangsu Nanfang Medical
SHG:603880
|
China | CN¥733.89 Million |
|
Proact IT Group AB
ST:PACT
|
Sweden | Skr3.38 Billion |
|
Celon Pharma SA
WAR:CLN
|
Poland | zł82.14 Million |
Liability Composition Analysis (2024–2024)
This chart breaks down Archimedes Tech SPAC Partners II Co. Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Archimedes Tech SPAC Partners II Co. Ord.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Archimedes Tech SPAC Partners II Co. Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Archimedes Tech SPAC Partners II Co. Ordinary Shares (2024–2024)
The table below shows the annual total liabilities of Archimedes Tech SPAC Partners II Co. Ordinary Shares from 2024 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $483.39K | -- |
About Archimedes Tech SPAC Partners II Co. Ordinary Shares
Archimedes Tech SPAC Partners II Co. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses in the technology industry. The company was incorporated in 2024 and is based in Claymont, Delaware.